$TGTX - On our trading list - Spec Biotech play with great risk and great potential. 100% ORR is good! Could see some interest in this one. TG Therapeutics Announces 100% Overall Response Rate in Relapsed/Refractory CLL Patients Treated With U2 (Umbralisib + Ublituximab) Plus Venetoclax at Cycle 7 (N=13) at ASH 2019 $TGTX, TG Therapeutics, Inc. / H1 Disclosure: I may trade in the ticker symbols mentioned, both long or short. My articles represent my personal opinion and analysis and should not be taken as investment advice. Readers should do their own research before making decisions to buy or sell securities. Trading and investing include risks, including loss of principal. If you liked this article, please click the LIKE (thumbs up) button. Feel free to leave any comments, question, or opinions. (Sign-up if you haven't already done so). Follow us/bookmark us and check back occasionally for additional articles or comments on our page... Wild Tiger Trading - start/main page